MedTrace Logo

Lord´s Procedure Versus Sclerotherapy for Testicular Hydrocele; a Randomized Controlled Study

NCT02082613 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-04-07

No results posted yet for this study

Summary

This study will compare a minimal invasive operation in local anesthesia with sclerotherapy for symptomatic testicular hydrocele within 6 months after randomization. Thirty days complication rates will be assessed. The hypothesis is that surgery will lead to faster cure while sclerotherapy would be cheaper and have less complications.

Conditions

  • Testicular Hydrocele

Interventions

PROCEDURE

Lord´s procedure

PROCEDURE

Sclerotherapy

Sponsors & Collaborators

  • Umeå University

    lead OTHER

Principal Investigators

  • Pär Nordin, Ph.D, MD · Umeå University

  • Karl-Johan Lundström, M.D · Östersunds Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-12-31
Completion
2017-04-30

Countries

  • Norway
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02082613 on ClinicalTrials.gov